- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Dictaphone exits from bankruptcy
As one imaging company nears the brink of insolvency, another has emerged from it. Dictaphone, an early developer of dictation and speech recognition technology, has formally shaken loose the bonds of Chapter 11. The Stratford, CT, company is now an
As one imaging company nears the brink of insolvency, another has emerged from it. Dictaphone, an early developer of dictation and speech recognition technology, has formally shaken loose the bonds of Chapter 11. The Stratford, CT, company is now an independent company and no longer a subsidiary of its former parent Lernout & Hauspie Speech Products. The official emergence follows the development of a reorganization plan accepted March 13 by the U.S. Bankruptcy Court for the District of Delaware. According to the plan, Dictaphone's unsecured creditors now own 100% of the common stock of the company, prior to customary dilution for the company's incentive program. Certain creditors received warrants for the rights to acquire additional shares. Other creditors received, in the aggregate, $27.3 million of subordinated notes to be newly issued by the company. Dictaphone has also secured a $30 million commitment from GMAC Business Credit under a revolving credit facility to meet ongoing needs for working capital.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
